In particular, our findings pointed to a truly novel mechanism of TERT up-regulation in cancer (differing substantially from that of the activating point mutations reported elsewhere [2, 3]) and raise some provocative questions, regarding the precise role of mtDNA mutations, in cancers utilizing oxidative phosphorylation. The gene discussed is TERT; the disease is cancer.